Transaction · 0001960048-26-000013

Cowan Elvia

Cowan Elvia, SVP, CAO, reported a transaction classified as exercise at Vaxcyte, Inc. involving 19000.000000 shares for an estimated $492480.00. Reported holdings after the transaction were 46860.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MSVP, CAO
PCVXVaxcyte, Inc.
Filing timeOct 07
Trade dateOct 05, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$66.70
Pre-filing
1mo ago -8.3%1w ago -12.6%1d ago -15.3%
Returns since
7d30d90d180d1y

PCVX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PCVX since 2026-10-07Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001960048-26-000013
Common Stock
Transaction date
Oct 05, 2026
Filed Oct 07, 2026, 08:07 PM · 2d delay
Shares
19.0k sh
$25.92 per share
Estimated value
$492k
Computed from shares × price
Holdings after
46.8k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, Finance & CAO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

  2. F2

    Stock Option is fully vested and exercisable.

Original filing · 0001960048-26-000013
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PCVX